Cargando...
Engineering Escherichia coli for Soluble Expression and Single Step Purification of Active Human Lysozyme
Genetically engineered variants of human lysozyme represent promising leads in the battle against drug-resistant bacterial pathogens, but early stage development and testing of novel lysozyme variants is constrained by the lack of a robust, scalable and facile expression system. While wild type huma...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3594478/ https://ncbi.nlm.nih.gov/pubmed/23220215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jbiotec.2012.11.007 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|